North America’s medical devices industry saw a drop of 17.3% in overall deal activity during Q4 2020, when compared to the four-quarter average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
A total of 220 deals worth $16.93bn were announced for the region during Q4 2020, against the last four-quarter average of 266 deals.
Of all the deal types, venture financing saw most activity in Q4 2020 with 127, representing a 57.7% share for the region.
In second place was M&A with 70 deals, followed by private equity deals with 23 transactions, respectively capturing a 31.8% and 10.5% share of the overall deal activity for the quarter.
In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $11.94bn, while private equity and venture financing deals totalled $2.69bn and $2.31bn, respectively.
North America medical devices industry deals in Q4 2020: Top deals
The top five medical devices deals accounted for 55.03% of the overall value during Q4 2020.
The combined value of the top five medical devices deals stood at $9.32bn, against the overall value of $16.93bn recorded for the quarter.
The top five medical devices industry deals of Q4 2020 tracked by GlobalData were:
1) Koninklijke Philips’ $2.8bn acquisition of BioTelemetry
2) The $2.15bn acquisition of Thrive Earlier Detection by Exact Sciences
3) AdaptHealth’s $2bn acquisition of AeroCare
4) The $1.5bn acquisition of Butterfly Network by Longview Acquisition
5) Casdin Capital and Rock Springs Capital Management’s private equity deal with Exact Sciences for $869.2m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.